This webinar is part 3 in a 3-part curriculum.
Program Description
The management of non-small
cell lung cancer (NSCLC) has evolved significantly with the integration of
precision medicine. This approach allows for the selection of therapies based
on a patient's specific tumor characteristics, which can lead to improved
survival outcomes and greater treatment efficacy. For oncology pharmacists,
being knowledgeable about this topic is crucial, as they play a central role in
interpreting these test results and applying them to treatment and management
decisions. This 3-part continuing education program, "Precision in
Practice for Oncology Pharmacists: Exploring Opportunities to Ensure Accuracy
in Non-Small Cell Lung Cancer Treatment," is designed to equip oncology
pharmacists with the knowledge and skills necessary to navigate this evolving
field and play a central role in delivering precision care in NSCLC. The series
consists of 2 webinars and a multidisciplinary panel discussion exploring the
current state of precision medicine in NSCLC, detailing its methodologies,
clinical applications, and practical implementation for oncology pharmacists.
Explore each of these activities to advance your knowledge and skills in
precision medicine for NSCLC, and learn how to apply these concepts to improve
patient care within your own practice.
Target Audience: Oncology Pharmacist
Type of Activity: Application
Release date: November
10, 2025
Expiration date: November
10, 2026
Learner
level: Intermediate
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Document the unique and shared barriers to optimal biomarker testing across academic institutions and community-based environments
- Identify pharmacist-led interventions to improve biomarker testing practices in non-small cell lung cancer
- Exercise best practices that have optimized biomarker testing workflows in NSCLC

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
